WallStSmart

HealthEquity Inc (HQY)vsVSee Health, Inc. (VSEE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

HealthEquity Inc generates 9004% more annual revenue ($1.31B vs $14.43M). HQY leads profitability with a 16.4% profit margin vs -69.8%. VSEE trades at a lower P/E of 0.6x. HQY earns a higher WallStSmart Score of 68/100 (B-).

HQY

Strong Buy

68

out of 100

Grade: B-

Growth: 8.0Profit: 7.0Value: 10.0Quality: 6.5
Piotroski: 4/9

VSEE

Avoid

29

out of 100

Grade: F

Growth: 6.7Profit: 2.0Value: 8.3Quality: 4.5
Piotroski: 2/9Altman Z: -5.95
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HQYUndervalued (+33.2%)

Margin of Safety

+33.2%

Fair Value

$115.13

Current Price

$82.47

$32.66 discount

UndervaluedFair: $115.13Overvalued
VSEEUndervalued (+89.7%)

Margin of Safety

+89.7%

Fair Value

$3.13

Current Price

$0.24

$2.89 discount

UndervaluedFair: $3.13Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HQY3 strengths · Avg: 8.7/10
EPS GrowthGrowth
92.4%10/10

Earnings expanding 92.4% YoY

PEG RatioValuation
0.898/10

Growing faster than its price suggests

Operating MarginProfitability
21.6%8/10

Strong operational efficiency at 21.6%

VSEE3 strengths · Avg: 9.3/10
P/E RatioValuation
0.6x10/10

Attractively priced relative to earnings

Debt/EquityHealth
-516.4310/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
18.7%8/10

18.7% revenue growth

Areas to Watch

HQY1 concerns · Avg: 4.0/10
P/E RatioValuation
33.4x4/10

Premium valuation, high expectations priced in

VSEE4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$11.24M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-2.6%2/10

ROE of -2.6% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : HQY

The strongest argument for HQY centers on EPS Growth, PEG Ratio, Operating Margin. Profitability is solid with margins at 16.4% and operating margin at 21.6%. PEG of 0.89 suggests the stock is reasonably priced for its growth.

Bull Case : VSEE

The strongest argument for VSEE centers on P/E Ratio, Debt/Equity, Revenue Growth. Revenue growth of 18.7% demonstrates continued momentum.

Bear Case : HQY

The primary concerns for HQY are P/E Ratio.

Bear Case : VSEE

The primary concerns for VSEE are EPS Growth, Market Cap, Piotroski F-Score.

Key Dynamics to Monitor

HQY profiles as a mature stock while VSEE is a growth play — different risk/reward profiles.

VSEE carries more volatility with a beta of 0.50 — expect wider price swings.

VSEE is growing revenue faster at 18.7% — sustainability is the question.

HQY generates stronger free cash flow (102M), providing more financial flexibility.

Bottom Line

HQY scores higher overall (68/100 vs 29/100), backed by strong 16.4% margins. VSEE offers better value entry with a 89.7% margin of safety. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

HealthEquity Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

HealthEquity, Inc. provides technology-enabled service platforms to consumers and employers in the United States. The company is headquartered in Draper, Utah.

VSee Health, Inc.

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

VSee Health, Inc. is a pioneering force in the telehealth industry, delivering secure and user-centric video communication solutions specifically designed for healthcare providers and patients. The comprehensive platform offers a suite of functionalities, including remote patient monitoring, asynchronous messaging, and electronic medical record (EMR) interoperability, aimed at optimizing healthcare delivery efficiency and quality across various specialties. With an unwavering focus on enhancing patient engagement and accessibility, VSee serves a diverse global clientele of healthcare institutions. As virtual care continues to gain traction, VSee Health is strategically positioned to leverage its technological innovations and expand its influence within the evolving healthcare market.

Visit Website →

Want to dig deeper into these stocks?